Search research articles
Contact Us
Filters
Showing results (1-10 of 118) with videos related to
Page
of 12
Sort By:
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
February 18, 2003
Diketopiperazines in peptide and combinatorial chemistry
Peter M Fischer
Medicinal Research Reviews
|
October 25, 2016
Approved and Experimental Small-Molecule Oncology Kinase Inhibitor Drugs: A Mid-2016 Overview
Peter M Fischer
Chemistry & Biology
|
January 1, 2004
CDK versus GSK-3 inhibition: a purple haze no longer?
Peter M Fischer
Cell Cycle (Georgetown, Tex.)
|
May 1, 2004
The use of CDK inhibitors in oncology: a pharmaceutical perspective
Peter M Fischer
Medicinal Research Reviews
|
October 5, 2006
Cellular uptake mechanisms and potential therapeutic utility of peptidic cell delivery vectors: progress 2001-2006
Peter M Fischer
Journal of Medicinal Chemistry
|
October 27, 2017
Design of Small-Molecule Active-Site Inhibitors of the S1A Family Proteases as Procoagulant and Anticoagulant Drugs
Peter M Fischer
Expert Opinion on Investigational Drugs
|
June 5, 2003
CNIO cancer conference: targeted search for anticancer drugs
Peter M Fischer
International Journal of Peptide Research and Therapeutics
|
July 21, 2009
Peptide, Peptidomimetic, and Small-molecule Antagonists of the p53-HDM2 Protein-Protein Interaction
Peter M Fischer
Cell Cycle (Georgetown, Tex.)
|
July 15, 2009
Cap in hand: targeting eIF4E
Peter M Fischer
Biotechnology Journal
|
April 17, 2008
Computational chemistry approaches to drug discovery in signal transduction
Peter M Fischer
Page
of 12
Search research articles
Search
Showing results (1-10 of 118) with videos related to
Sort By:
Page
of 12
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
February 18, 2003
Diketopiperazines in peptide and combinatorial chemistry
Peter M Fischer
Medicinal Research Reviews
|
October 25, 2016
Approved and Experimental Small-Molecule Oncology Kinase Inhibitor Drugs: A Mid-2016 Overview
Peter M Fischer
Chemistry & Biology
|
January 1, 2004
CDK versus GSK-3 inhibition: a purple haze no longer?
Peter M Fischer
Cell Cycle (Georgetown, Tex.)
|
May 1, 2004
The use of CDK inhibitors in oncology: a pharmaceutical perspective
Peter M Fischer
Medicinal Research Reviews
|
October 5, 2006
Cellular uptake mechanisms and potential therapeutic utility of peptidic cell delivery vectors: progress 2001-2006
Peter M Fischer
Journal of Medicinal Chemistry
|
October 27, 2017
Design of Small-Molecule Active-Site Inhibitors of the S1A Family Proteases as Procoagulant and Anticoagulant Drugs
Peter M Fischer
Expert Opinion on Investigational Drugs
|
June 5, 2003
CNIO cancer conference: targeted search for anticancer drugs
Peter M Fischer
International Journal of Peptide Research and Therapeutics
|
July 21, 2009
Peptide, Peptidomimetic, and Small-molecule Antagonists of the p53-HDM2 Protein-Protein Interaction
Peter M Fischer
Cell Cycle (Georgetown, Tex.)
|
July 15, 2009
Cap in hand: targeting eIF4E
Peter M Fischer
Biotechnology Journal
|
April 17, 2008
Computational chemistry approaches to drug discovery in signal transduction
Peter M Fischer
Page
of 12